Apyx Medical Corporation
APYX
$3.99
-$0.04-0.99%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.98M | -3.78M | -4.15M | -4.63M | -4.70M |
| Total Depreciation and Amortization | 164.00K | 132.00K | 138.00K | 142.00K | 144.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.00M | 1.12M | 717.00K | 1.94M | 1.36M |
| Change in Net Operating Assets | -2.72M | 1.29M | 2.59M | -394.00K | -1.24M |
| Cash from Operations | -3.54M | -1.23M | -702.00K | -2.94M | -4.44M |
| Capital Expenditure | -519.00K | -265.00K | -55.00K | -245.00K | -153.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -519.00K | -265.00K | -55.00K | -245.00K | -153.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.00K | -5.00K | -5.00K | -5.00K | -5.00K |
| Issuance of Common Stock | 49.00K | -- | -- | 7.00M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 30.00K | 30.00K | -235.00K | -- |
| Cash from Financing | 45.00K | 25.00K | 25.00K | 6.76M | -5.00K |
| Foreign Exchange rate Adjustments | -156.00K | -237.00K | 2.00K | 150.00K | -67.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.17M | -1.71M | -730.00K | 3.73M | -4.67M |